49 recalls tagged with “pet related”.
Extract Labs recalled 19,750 gummies on August 26, 2025, due to potential peanut protein cross-contact. The products, which contain 20mg of CBD and 20mg of D9 THC per gummy, lack proper labeling. Consumers should not consume these gummies and should contact the company for refunds or replacements.
Extract Labs recalled 19,810 units of Blue Razz 20mg Gummies on August 26, 2025. The recall follows concerns about potential peanut protein cross-contact. Consumers should not consume the product and should seek a refund.
Extract Labs recalled 2,180 bottles of sugar-free mixed berry gummies on August 26, 2025. The recall stems from potential peanut protein cross-contact, posing a risk to consumers with allergies. The gummies contain 10mg of CBD and 10mg of D9 THC per serving.
Extract Labs recalled 19,720 Elderberry gummies on August 26, 2025 due to potential peanut protein cross-contact. The gummies, containing 20mg CBD and 20mg D9 THC each, were shipped unlabeled in bulk packaging. Consumers should not consume these products and seek refunds or replacements.
Abdallah Candies recalled one box of Cream Caramels on August 25, 2025. The product contains undeclared allergens, specifically peanuts and pecans. This poses a serious risk to consumers with nut allergies.
Abdallah Candies recalled Sea Salt Caramel Dark Miniature on August 25, 2025. The recall affects one 5.20 lb box due to undeclared allergens. Consumers should not consume the product and seek a refund immediately.
Anderson Candy Company recalled 960,000 units of Peanut Rounds on August 15, 2025. The recall stems from undeclared soy allergens that pose a serious health risk. The affected products were distributed in several states including Texas and Louisiana.
The Candy Barn recalled 665 packages of Grandma's Old-Fashioned Peanut Brittle on August 6, 2025. The packaging failed to list peanuts and milk as allergens. Consumers should avoid the product and seek a refund.
Summa Therapeutics recalled 22 units of the Finesse BTK Multicath Injectable Angioplasty Balloon Catheter sold to healthcare facilities in New Jersey and Florida. The balloon may not meet burst specifications, raising risk during angioplasty. Healthcare providers must stop using the device immediately and follow recall instructions from Summa Therapeutics.